Bond.az White LogoBond.az Black Logo

TD Cowen raises Nvidia price target to $275 on AI demand

TD Cowen raises Nvidia price target to $275 on AI demand and strong fundamentals. Read more on Bond.az.

Sebastian Young
BySebastian Young- Senior Editor
|
0

Bond.az - TD Cowen raised its price target on Nvidia Corp. shares to $275 from $235 while maintaining a Buy rating.

Analyst Joshua Buchalter cited strong fundamentals and ongoing hyperscale capital expenditure expansion. He noted Nvidia (NASDAQ:NVDA) continues to capture a disproportionate share of that spending.

Management's order pipeline for Blackwell and Rubin products exceeds $1 trillion, suggesting potential upside to Street estimates and extended visibility. TD Cowen expects Nvidia to meet or exceed its typical quarterly sales beat of approximately $1 billion to $2 billion.

The company's results and guidance are expected to reinforce its leadership in AI acceleration despite recent stock underperformance and shifting investor focus across the AI supply chain.

TD Cowen raised estimates for the company. The shares trade at approximately 20 times calendar 2027 estimates, which the firm believes have upside bias. The stock currently trades at a P/E ratio of 48.13, though its PEG ratio of 0.63 suggests attractive value relative to growth. According to Bond.az analysis, the stock appears fairly valued at current levels.

In other recent news, UBS raised its price target for Nvidia to $275, citing strong demand outlook and projecting first-quarter revenue to reach around $81 billion. Cantor Fitzgerald also increased its price target to $350. Wolfe Research maintains Nvidia as its top pick among AI compute stocks. RBC Capital reiterated an Outperform rating with a $250 price target. On the downside, Culper Research has taken a short position against Nvidia, alleging illegal GPU sales to China through intermediaries.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
841

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
TD Cowen raises Nvidia price target to $275 on AI demand | Bond.az